Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9936 |
High Similarity |
NPD4171 |
Clinical (unspecified phase) |
0.9038 |
High Similarity |
NPD339 |
Approved |
0.8974 |
High Similarity |
NPD338 |
Approved |
0.8861 |
High Similarity |
NPD169 |
Phase 2 |
0.8846 |
High Similarity |
NPD283 |
Approved |
0.8734 |
High Similarity |
NPD242 |
Approved |
0.8538 |
High Similarity |
NPD4744 |
Clinical (unspecified phase) |
0.848 |
Intermediate Similarity |
NPD4716 |
Approved |
0.8462 |
Intermediate Similarity |
NPD249 |
Approved |
0.8462 |
Intermediate Similarity |
NPD250 |
Approved |
0.8385 |
Intermediate Similarity |
NPD1369 |
Phase 2 |
0.8354 |
Intermediate Similarity |
NPD195 |
Approved |
0.8354 |
Intermediate Similarity |
NPD186 |
Discovery |
0.8272 |
Intermediate Similarity |
NPD1750 |
Clinical (unspecified phase) |
0.8272 |
Intermediate Similarity |
NPD3107 |
Discontinued |
0.8253 |
Intermediate Similarity |
NPD3083 |
Approved |
0.8232 |
Intermediate Similarity |
NPD2624 |
Phase 2 |
0.8232 |
Intermediate Similarity |
NPD2646 |
Discontinued |
0.8214 |
Intermediate Similarity |
NPD7988 |
Suspended |
0.815 |
Intermediate Similarity |
NPD1412 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD1732 |
Phase 3 |
0.8107 |
Intermediate Similarity |
NPD247 |
Clinical (unspecified phase) |
0.8101 |
Intermediate Similarity |
NPD185 |
Approved |
0.8072 |
Intermediate Similarity |
NPD4074 |
Clinical (unspecified phase) |
0.8034 |
Intermediate Similarity |
NPD6417 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD166 |
Approved |
0.7975 |
Intermediate Similarity |
NPD193 |
Suspended |
0.7849 |
Intermediate Similarity |
NPD2647 |
Phase 3 |
0.7845 |
Intermediate Similarity |
NPD2632 |
Approved |
0.7845 |
Intermediate Similarity |
NPD2630 |
Approved |
0.7845 |
Intermediate Similarity |
NPD2631 |
Clinical (unspecified phase) |
0.7829 |
Intermediate Similarity |
NPD5666 |
Phase 2 |
0.7758 |
Intermediate Similarity |
NPD3085 |
Phase 1 |
0.7722 |
Intermediate Similarity |
NPD1692 |
Approved |
0.7711 |
Intermediate Similarity |
NPD3086 |
Phase 3 |
0.7697 |
Intermediate Similarity |
NPD548 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD218 |
Approved |
0.7692 |
Intermediate Similarity |
NPD216 |
Approved |
0.7692 |
Intermediate Similarity |
NPD217 |
Approved |
0.7692 |
Intermediate Similarity |
NPD220 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD219 |
Phase 3 |
0.7515 |
Intermediate Similarity |
NPD213 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD214 |
Approved |
0.7514 |
Intermediate Similarity |
NPD4054 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD7158 |
Phase 1 |
0.7296 |
Intermediate Similarity |
NPD248 |
Discontinued |
0.7288 |
Intermediate Similarity |
NPD1777 |
Approved |
0.7288 |
Intermediate Similarity |
NPD1776 |
Approved |
0.7283 |
Intermediate Similarity |
NPD546 |
Clinical (unspecified phase) |
0.7258 |
Intermediate Similarity |
NPD5682 |
Phase 3 |
0.7258 |
Intermediate Similarity |
NPD5684 |
Clinical (unspecified phase) |
0.7258 |
Intermediate Similarity |
NPD5683 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD9633 |
Phase 3 |
0.7188 |
Intermediate Similarity |
NPD9632 |
Phase 3 |
0.717 |
Intermediate Similarity |
NPD870 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD9408 |
Phase 3 |
0.7108 |
Intermediate Similarity |
NPD3696 |
Approved |
0.7108 |
Intermediate Similarity |
NPD3695 |
Approved |
0.7073 |
Intermediate Similarity |
NPD252 |
Clinical (unspecified phase) |
0.6966 |
Remote Similarity |
NPD516 |
Clinical (unspecified phase) |
0.6947 |
Remote Similarity |
NPD7138 |
Phase 2 |
0.6905 |
Remote Similarity |
NPD549 |
Approved |
0.6895 |
Remote Similarity |
NPD1063 |
Phase 2 |
0.6893 |
Remote Similarity |
NPD5080 |
Phase 2 |
0.6845 |
Remote Similarity |
NPD5079 |
Phase 2 |
0.6839 |
Remote Similarity |
NPD3708 |
Phase 2 |
0.6807 |
Remote Similarity |
NPD194 |
Clinical (unspecified phase) |
0.6784 |
Remote Similarity |
NPD4240 |
Approved |
0.6766 |
Remote Similarity |
NPD2965 |
Clinical (unspecified phase) |
0.6761 |
Remote Similarity |
NPD536 |
Clinical (unspecified phase) |
0.6733 |
Remote Similarity |
NPD2876 |
Phase 3 |
0.6733 |
Remote Similarity |
NPD2877 |
Clinical (unspecified phase) |
0.6725 |
Remote Similarity |
NPD582 |
Approved |
0.6667 |
Remote Similarity |
NPD2824 |
Phase 2 |
0.6651 |
Remote Similarity |
NPD6840 |
Approved |
0.661 |
Remote Similarity |
NPD353 |
Discontinued |
0.6579 |
Remote Similarity |
NPD1046 |
Clinical (unspecified phase) |
0.6552 |
Remote Similarity |
NPD171 |
Discontinued |
0.6538 |
Remote Similarity |
NPD2903 |
Clinical (unspecified phase) |
0.6538 |
Remote Similarity |
NPD2902 |
Phase 2 |
0.6522 |
Remote Similarity |
NPD4495 |
Phase 1 |
0.6389 |
Remote Similarity |
NPD231 |
Clinical (unspecified phase) |
0.6298 |
Remote Similarity |
NPD9605 |
Phase 3 |
0.6205 |
Remote Similarity |
NPD7502 |
Clinical (unspecified phase) |
0.6196 |
Remote Similarity |
NPD9606 |
Approved |
0.6159 |
Remote Similarity |
NPD9607 |
Approved |
0.6145 |
Remote Similarity |
NPD1730 |
Discontinued |
0.6078 |
Remote Similarity |
NPD8250 |
Phase 2 |
0.6069 |
Remote Similarity |
NPD209 |
Clinical (unspecified phase) |
0.6058 |
Remote Similarity |
NPD4458 |
Phase 2 |
0.6058 |
Remote Similarity |
NPD4459 |
Clinical (unspecified phase) |
0.6057 |
Remote Similarity |
NPD6112 |
Approved |
0.6024 |
Remote Similarity |
NPD9409 |
Discontinued |
0.6023 |
Remote Similarity |
NPD799 |
Phase 1 |
0.6012 |
Remote Similarity |
NPD545 |
Clinical (unspecified phase) |
0.6 |
Remote Similarity |
NPD527 |
Clinical (unspecified phase) |
0.599 |
Remote Similarity |
NPD2152 |
Clinical (unspecified phase) |
0.5947 |
Remote Similarity |
NPD2593 |
Clinical (unspecified phase) |
0.5943 |
Remote Similarity |
NPD1119 |
Phase 2 |
0.5922 |
Remote Similarity |
NPD2253 |
Discontinued |
0.592 |
Remote Similarity |
NPD547 |
Clinical (unspecified phase) |
0.5915 |
Remote Similarity |
NPD9374 |
Approved |
0.589 |
Remote Similarity |
NPD9373 |
Approved |
0.5886 |
Remote Similarity |
NPD1058 |
Discontinued |
0.5882 |
Remote Similarity |
NPD9084 |
Phase 2 |
0.5877 |
Remote Similarity |
NPD5486 |
Discontinued |
0.5868 |
Remote Similarity |
NPD307 |
Approved |
0.5862 |
Remote Similarity |
NPD282 |
Approved |
0.5856 |
Remote Similarity |
NPD6381 |
Phase 2 |
0.5847 |
Remote Similarity |
NPD7531 |
Clinical (unspecified phase) |
0.5833 |
Remote Similarity |
NPD1430 |
Approved |
0.5833 |
Remote Similarity |
NPD1431 |
Approved |
0.5815 |
Remote Similarity |
NPD775 |
Approved |
0.5794 |
Remote Similarity |
NPD5458 |
Discontinued |
0.5775 |
Remote Similarity |
NPD34 |
Approved |
0.5775 |
Remote Similarity |
NPD4714 |
Approved |
0.5775 |
Remote Similarity |
NPD4713 |
Clinical (unspecified phase) |
0.5775 |
Remote Similarity |
NPD4715 |
Clinical (unspecified phase) |
0.5767 |
Remote Similarity |
NPD2452 |
Phase 2 |
0.5767 |
Remote Similarity |
NPD2450 |
Phase 2 |
0.5767 |
Remote Similarity |
NPD2453 |
Phase 2 |
0.5767 |
Remote Similarity |
NPD2451 |
Phase 2 |
0.5756 |
Remote Similarity |
NPD207 |
Discontinued |
0.5714 |
Remote Similarity |
NPD8829 |
Clinical (unspecified phase) |
0.5708 |
Remote Similarity |
NPD4599 |
Clinical (unspecified phase) |
0.5706 |
Remote Similarity |
NPD9083 |
Clinical (unspecified phase) |
0.569 |
Remote Similarity |
NPD1127 |
Approved |
0.569 |
Remote Similarity |
NPD1128 |
Approved |
0.5667 |
Remote Similarity |
NPD1808 |
Phase 1 |
0.5649 |
Remote Similarity |
NPD6351 |
Discovery |
0.5629 |
Remote Similarity |
NPD9584 |
Phase 2 |
0.5628 |
Remote Similarity |
NPD4089 |
Clinical (unspecified phase) |
0.5625 |
Remote Similarity |
NPD4555 |
Clinical (unspecified phase) |
0.5619 |
Remote Similarity |
NPD6036 |
Suspended |
0.5604 |
Remote Similarity |
NPD1118 |
Discontinued |
0.5602
|
Remote Similarity |
NPD1017 |
Clinical (unspecified phase) |